Boehringer Ingelheim und die WHO Foundation starten eine weltweite Zusammenarbeit, um die Versorgungslücke im Bereich Adipositas und Stoffwechselgesundheit zu schließen
Unterstützung im Bereich Adipositas und Stoffwechselgesundheit durch einen Beitrag von Boehringer Ingelheim in Höhe von 5 Millionen US-Dollar über drei Jahre Die Zusammenarbeit wird die integrierte Versorgung bei Adipositas und damit verbundenen Herz-Kreislauf-, Nieren-, Leber- und...
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Abre en Noruega el mayor centro de experiencia de servicios de NING en Europa
- Johnson & Johnson announces TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to show significant improvement in spinal pain and stiffness in landmark axial psoriatic arthritis (PsA) study
- Did Future FinTech Group Inc. Insiders Breach their Fiduciary Duties to Shareholders?
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →